Viewing Study NCT03016260

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-02-28 @ 6:47 PM
Study NCT ID: NCT03016260
Status: TERMINATED
Last Update Posted: 2019-12-24
First Post: 2017-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis
Sponsor: TcLand Expression S.A.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None RheumatoId Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rheumatoid Arthritis View
None Anti TNF View
None Infliximab View
None Adalimumab View
None Etanercept View
None Golimumab View
None Certolizumab Pegol View
None Infliximab biosimilar View
None Etanercept biosimilar View
None Methotrexate View